NIH PAR · NCI · U24
PAR-28-057: Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is soliciting applications for the establishment of the Management and Data Coordination Unit (MDCU), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC). The PCDC will continue to address one of the four research priorities identified in the National Cancer Institute's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma and conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions to identify those patients who are at high risk of progression to cancer. The PCDC-MDCU will provide support…
- NOFO number
- PAR-28-057
- Type
- PAR
- Activity code
- U24
- Primary institute
- NCI · National Cancer Institute
- Clinical trials
- Not Allowed
- Posted
- Sep 25, 2026
- Opens
- Dec 25, 2026
- Expires
- May 26, 2027
PAR-28-057 due dates
2 application due dates remain before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| January 25, 2027 * | January 25, 2027 * | Not Applicable | July 2027 | October 2027 | December 2027 |
| May 25, 2027 * | May 25, 2027 * | Not Applicable | November 2027 | January 2028 | April 2028 |
What its predecessor PAR-21-335 funded
PAR-28-057 reissues PAR-21-335. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 1 project and $3.3M in FY2022–FY2026.
Projects funded
1
Distinct projects, FY2022–FY2026
New awards
1
Type 1 (new project) award records
NIH funding
$3.3M
Award dollars under PAR-21-335, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 1 | 1 | $660K |
| FY2023 | 1 | 0 | $647K |
| FY2024 | 1 | 0 | $627K |
| FY2025 | 1 | 0 | $660K |
| FY2026 | 1 | 0 | $660K |
Institutions with the most funding
- Mayo Clinic Rochester$3.3M · 1 project
Funding institutes
- NCI$3.3M · 5
Activity codes funded
- U245 records
Most recent new awards
- Management and Data Coordination Unit for PCDC (opens NIH RePORTER)
Mayo Clinic Rochester · 1U24CA274496-01 · NCI · Notice Aug 29, 2022
$660KU24
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-28-057. Contact the program officer at the institute that fits your research before applying.
- NCI · National Cancer Institute
- none
Related notices
NIH lists no related notices for PAR-28-057 yet.
Award terms
- Application types allowed
- New Renewal Resubmission Revision The OER Glossary and the How to Apply - Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- The maximum amount per award may not exceed 500K direct cost per year. Application budgets need to reflect the actual needs of the proposed project.
- Project period
- The project period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- NCI intends to commit an estimated total of 825K total cost per year to fund one award.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-21-335.
- Companion NOFOs: PAR-28-056.
Other open NOFOs for U24
- RFA-CA-27-020Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)NCI · next due Oct 19, 2026
- RFA-CA-27-021Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)NCI · next due Oct 19, 2026
- RFA-CA-28-004Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)NCI · next due Feb 11, 2027
- RFA-AG-27-010Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)NIA · next due Nov 10, 2026
- RFA-HG-27-008IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)NHGRI · next due Dec 14, 2026
- PAR-27-013Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)NHLBI · next due Feb 1, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.